Concord Drugs Ltd — Board Meeting, 27-06-2025: Board Meeting

Concord Drugs has announced a board meeting and decided to temporarily hold off on its plan to raise funds through a preferential share issue and increase its authorized capital. The company will revisit this proposal at a later date. This pause reflects a cautious approach towards funding and capital structure changes, impacting how the company might support future growth or expansion efforts. Further updates will be provided if required.